{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:58:27Z","timestamp":1759334307910,"version":"build-2065373602"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-07861-2","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:43:18Z","timestamp":1759239798000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of probiotic co-supplementation with omega-3 PUFAs on pancreatic beta-cell function in type 2 diabetes"],"prefix":"10.1038","volume":"15","author":[{"given":"Maryana","family":"Savytska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmytro","family":"Kyriienko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galyna","family":"Mykhalchyshyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olena","family":"Tsyryuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatyana","family":"Falalyeyeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9814-689X","authenticated-orcid":false,"given":"Nazarii","family":"Kobyliak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"7861_CR1","doi-asserted-by":"publisher","first-page":"e0251646","DOI":"10.1371\/journal.pone.0251646","volume":"16","author":"PS Hsieh","year":"2021","unstructured":"Hsieh, P. S. et al. Multi-strain probiotic supplement attenuates streptozotocin-induced type-2 diabetes by reducing inflammation and \u03b2-cell death in rats. PLOS ONE. 16, e0251646 (2021).","journal-title":"PLOS ONE"},{"key":"7861_CR2","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.smim.2012.12.001","volume":"24","author":"CJ Shu","year":"2012","unstructured":"Shu, C. J., Benoist, C. & Mathis, D. The immune system\u2019s involvement in obesity-driven type 2 diabetes. Semin. Immunol. 24, 436\u2013442 (2012).","journal-title":"Semin. Immunol."},{"key":"7861_CR3","doi-asserted-by":"publisher","first-page":"7204","DOI":"10.18632\/oncotarget.23208","volume":"9","author":"L Chen","year":"2018","unstructured":"Chen, L. et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 9, 7204\u20137218 (2018).","journal-title":"Oncotarget"},{"key":"7861_CR4","doi-asserted-by":"publisher","first-page":"172","DOI":"10.23736\/S0391-1977.20.03161-2","volume":"45","author":"M Aludwan","year":"2020","unstructured":"Aludwan, M. et al. Vitamin D3 deficiency is associated with more severe insulin resistance and Metformin use in patients with type 2 diabetes. Minerva Endocrinol. 45, 172\u2013180 (2020).","journal-title":"Minerva Endocrinol."},{"key":"7861_CR5","doi-asserted-by":"crossref","unstructured":"Mykhalchyshyn, G., Kobyliak, N. & Bodnar, P. Diagnostic accuracy of acyl-ghrelin and it association with nonalcoholic fatty liver disease in type 2 diabetic patients. J. Diabetes Metab. Disord. 14, (2015).","DOI":"10.1186\/s40200-015-0170-1"},{"key":"7861_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11892-019-1196-4","volume":"19","author":"AA Christensen","year":"2019","unstructured":"Christensen, A. A. & Gannon, M. The Beta cell in type 2 diabetes. Curr. Diab. Rep. 19, 81 (2019).","journal-title":"Curr. Diab. Rep."},{"key":"7861_CR7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41574-020-0355-7","volume":"16","author":"DL Eizirik","year":"2020","unstructured":"Eizirik, D. L., Pasquali, L. & Cnop, M. Pancreatic \u03b2-cells in type 1 and type 2 diabetes mellitus: different pathways to failure. Nat. Reviews Endocrinol. 16, 349\u2013362 (2020).","journal-title":"Nat. Reviews Endocrinol."},{"key":"7861_CR8","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","volume":"110","author":"HJ Teede","year":"2018","unstructured":"Teede, H. J. et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil. Steril. 110, 364\u2013379 (2018).","journal-title":"Fertil. Steril."},{"key":"7861_CR9","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jdiacomp.2015.12.027","volume":"30","author":"C Nederstigt","year":"2016","unstructured":"Nederstigt, C., Corssmit, E. P. M., De Koning, E. J. P. & Dekkers, O. M. Incidence and prevalence of thyroid dysfunction in type 1 diabetes. J. Diabetes Complicat. 30, 420\u2013425 (2016).","journal-title":"J. Diabetes Complicat."},{"key":"7861_CR10","first-page":"434","volume":"102","author":"Y Gu","year":"2017","unstructured":"Gu, Y. et al. The relationship between thyroid function and the prevalence of type 2 diabetes mellitus in euthyroid subjects. J. Clin. Endocrinol. Metab. 102, 434\u2013442 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"7861_CR11","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1007\/s12029-019-00329-3","volume":"51","author":"M Eslami","year":"2020","unstructured":"Eslami, M. et al. Importance of the microbiota inhibitory mechanism on the Warburg effect in colorectal Cancer cells. J. Gastrointest. Cancer. 51, 738\u2013747 (2020).","journal-title":"J. Gastrointest. Cancer"},{"key":"7861_CR12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.23736\/S1120-4826.19.02548-5","volume":"31","author":"O Korotkyi","year":"2019","unstructured":"Korotkyi, O. et al. Effect of probiotic on serum cytokines and matrix metalloproteinases profiles during monoiodoacetate-induced osteoarthritis in rats. Minerva Biotecnologica. 31, 68\u201373 (2019).","journal-title":"Minerva Biotecnologica"},{"key":"7861_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/pedi.12773","volume":"19","author":"EJ Mayer-Davis","year":"2018","unstructured":"Mayer-Davis, E. J. et al. ISPAD clinical practice consensus guidelines 2018: definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr. Diabetes. 19, 7\u201319 (2018).","journal-title":"Pediatr. Diabetes"},{"key":"7861_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.33619\/2414-2948\/47\/11","volume":"5","author":"A Evseev","year":"2019","unstructured":"Evseev, A. Medical nutrition therapy in type 2 diabetes mellitus. Bull. Sci. Pract. 5, 77\u201383 (2019).","journal-title":"Bull. Sci. Pract."},{"key":"7861_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/gutjnl-2017-314786","volume":"68","author":"M Roager","year":"2019","unstructured":"Roager, M. Whole grain-rich diet reduces body weight and systemic low-grade inflammation without inducing major changes of the gut microbiome: A randomized crossover trial. Gut 68, 83\u201393 (2019).","journal-title":"Gut"},{"key":"7861_CR16","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.2337\/dc20-0263","volume":"43","author":"S \u00c5berg","year":"2020","unstructured":"\u00c5berg, S., Mann, J., Neumann, S., Ross, A. B. & Reynolds, A. N. Whole-grain processing and glycemic control in type 2 diabetes: A randomized crossover trial. Diabetes Care. 43, 1717\u20131723 (2020).","journal-title":"Diabetes Care"},{"key":"7861_CR17","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1093\/jn\/137.6.1401","volume":"137","author":"A Andersson","year":"2007","unstructured":"Andersson, A. et al. Whole-grain foods do not affect insulin sensitivity or markers of lipid peroxidation and inflammation in healthy, moderately overweight subjects. J. Nutr. 137, 1401\u20131407 (2007).","journal-title":"J. Nutr."},{"key":"7861_CR18","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s12967-019-02159-0","volume":"17","author":"L Wang","year":"2019","unstructured":"Wang, L. et al. Inulin-type Fructans supplementation improves glycemic control for the prediabetes and type 2 diabetes populations: results from a GRADE-assessed systematic review and dose\u2013response meta-analysis of 33 randomized controlled trials. J. Translational Med. 17, 410 (2019).","journal-title":"J. Translational Med."},{"key":"7861_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3164\/jcbn.19-103","volume":"66","author":"W Zhang","year":"2020","unstructured":"Zhang, W. et al. Efficacy of inulin supplementation in improving insulin control, HbA1c and HOMA-IR in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. J. Clin. Biochem. Nutr. 66, 176\u2013183 (2020).","journal-title":"J. Clin. Biochem. Nutr."},{"key":"7861_CR20","first-page":"1548","volume":"24","author":"D Pitocco","year":"2020","unstructured":"Pitocco, D. et al. The role of gut microbiota in mediating obesity and diabetes mellitus. Eur. Rev. Med. Pharmacol. Sci. 24, 1548\u20131562 (2020).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"7861_CR21","doi-asserted-by":"publisher","first-page":"634","DOI":"10.4254\/wjh.v14.i3.634","volume":"14","author":"E Manzhalii","year":"2022","unstructured":"Manzhalii, E. et al. Effect of a specific Escherichia coli Nissle 1917 strain on minimal\/mild hepatic encephalopathy treatment. World J. Hepatol. 14, 634\u2013646 (2022).","journal-title":"World J. Hepatol."},{"key":"7861_CR22","doi-asserted-by":"publisher","first-page":"242","DOI":"10.23736\/S2724-6507.22.03752-6","volume":"47","author":"N Kobyliak","year":"2022","unstructured":"Kobyliak, N. et al. Akkermansia muciniphila as a novel powerful bacterial player in the treatment of metabolic disorders. Minerva Endocrinol. 47, 242\u2013252 (2022).","journal-title":"Minerva Endocrinol."},{"key":"7861_CR23","doi-asserted-by":"publisher","first-page":"102590","DOI":"10.1016\/j.ebiom.2019.11.051","volume":"51","author":"M Gurung","year":"2020","unstructured":"Gurung, M. et al. Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine 51, 102590 (2020).","journal-title":"EBioMedicine"},{"key":"7861_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","volume":"19","author":"Y Fan","year":"2021","unstructured":"Fan, Y. & Pedersen, O. Gut microbiota in human metabolic health and disease. Nat. Rev. Microbiol. 19, 55\u201371 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"7861_CR25","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1080\/10408398.2014.934438","volume":"57","author":"L Bordalo Tonucci","year":"2017","unstructured":"Bordalo Tonucci, L. et al. Gut microbiota and probiotics: focus on diabetes mellitus. Crit. Rev. Food Sci. Nutr. 57, 2296\u20132309 (2017).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"7861_CR26","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3389\/fphys.2019.00428","volume":"10","author":"AM Martin","year":"2019","unstructured":"Martin, A. M., Sun, E. W., Rogers, G. B. & Keating, D. J. The influence of the gut Microbiome on host metabolism through the regulation of gut hormone release. Front. Physiol. 10, 428 (2019).","journal-title":"Front. Physiol."},{"key":"7861_CR27","doi-asserted-by":"publisher","first-page":"582","DOI":"10.2174\/1573399812666161014112515","volume":"13","author":"A Rad","year":"2017","unstructured":"Rad, A. The future of diabetes management by healthy probiotic microorganisms. Curr. Diabetes Rev. 13, 582\u2013589 (2017).","journal-title":"Curr. Diabetes Rev."},{"key":"7861_CR28","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/ije\/dyaa122","volume":"49","author":"J Yuan","year":"2020","unstructured":"Yuan, J. et al. Long-term use of antibiotics and risk of type 2 diabetes in women: a prospective cohort study. Int. J. Epidemiol. 49, 1572 (2020).","journal-title":"Int. J. Epidemiol."},{"key":"7861_CR29","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1210\/jc.2015-2696","volume":"100","author":"KH Mikkelsen","year":"2015","unstructured":"Mikkelsen, K. H., Knop, F. K., Frost, M., Hallas, J. & Pottegard, A. Use of antibiotics and risk of type 2 diabetes: A population-based case\u2013control study. J. Clin. Endocrinol. Metab. 100, 3633\u20133640 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"7861_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/bcp.12935","volume":"83","author":"JK Aronson","year":"2017","unstructured":"Aronson, J. K. Defining \u2018nutraceuticals\u2019: neither nutritious nor pharmaceutical. Br. J. Clin. Pharmacol. 83, 8\u201319 (2017).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"7861_CR31","doi-asserted-by":"publisher","first-page":"102361","DOI":"10.1016\/j.plefa.2021.102361","volume":"174","author":"M Ma","year":"2021","unstructured":"Ma, M. et al. Omega-3 index and type 2 diabetes: systematic review and meta-analysis. Prostaglandins, Leukot. Essent. Fatty Acids. 174, 102361 (2021).","journal-title":"Prostaglandins, Leukot. Essent. Fatty Acids"},{"key":"7861_CR32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13098-022-00804-1","volume":"14","author":"M Hu","year":"2022","unstructured":"Hu, M., Fang, Z., Zhang, T. & Chen, Y. Polyunsaturated fatty acid intake and incidence of type 2 diabetes in adults: a dose response meta-analysis of cohort studies. Diabetol. Metab. Syndr. 14, 34 (2022).","journal-title":"Diabetol. Metab. Syndr."},{"key":"7861_CR33","doi-asserted-by":"publisher","unstructured":"Flachs, P., Rossmeisl, M. & Kopecky, J. The effect of n-3 fatty acids on glucose homeostasis and insulin sensitivity. Physiol. Res. 93\u2013S118. https:\/\/doi.org\/10.33549\/physiolres.932715 (2014).","DOI":"10.33549\/physiolres.932715"},{"key":"7861_CR34","unstructured":"Ricordi, C. & Lanzoni, G. Can high-dose omega-3 fatty acids and high-dose vitamin D3 (cholecalciferol) prevent type 1 diabetes and sustain preservation of beta-cell function after disease onset? CellR4\u2013 repair, replacement, regeneration, & reprogramming 6, (2018)."},{"key":"7861_CR35","doi-asserted-by":"publisher","unstructured":"Brown, T. J. et al. Omega-3, omega-6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomized controlled trials. BMJ l4697. https:\/\/doi.org\/10.1136\/bmj.l4697 (2019).","DOI":"10.1136\/bmj.l4697"},{"key":"7861_CR36","doi-asserted-by":"crossref","unstructured":"Rajkumar, H. et al. Effect of probiotic (VSL#3) and omega-3 on lipid profile, insulin sensitivity, inflammatory markers, and gut colonization in overweight adults: A randomized, controlled trial. Mediators of Inflammation 348959 (2014). (2014).","DOI":"10.1155\/2014\/348959"},{"key":"7861_CR37","doi-asserted-by":"publisher","first-page":"418","DOI":"10.23736\/S0026-4806.18.05845-7","volume":"109","author":"N Kobyliak","year":"2018","unstructured":"Kobyliak, N. et al. Beneficial effects of probiotic combination with omega-3 fatty acids in NAFLD: a randomized clinical study. Minerva Med. 109, 418\u2013428 (2018).","journal-title":"Minerva Med."},{"key":"7861_CR38","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.3390\/nu13051655","volume":"13","author":"P Cronin","year":"2021","unstructured":"Cronin, P., Joyce, S. A., O\u2019Toole, P. W. & O\u2019Connor, E. M. Dietary Fiber modulates the gut microbiota. Nutrients 13, 1655 (2021).","journal-title":"Nutrients"},{"key":"7861_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1017\/S0029665120006916","volume":"80","author":"C Martin-Gallausiaux","year":"2021","unstructured":"Martin-Gallausiaux, C., Marinelli, L., Blotti\u00e8re, H. M., Larraufie, P. & Lapaque, N. SCFA: mechanisms and functional importance in the gut. Proc. Nutr. Soc. 80, 37\u201349 (2021).","journal-title":"Proc. Nutr. Soc."},{"key":"7861_CR40","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4239\/wjd.v10.i3.154","volume":"10","author":"Y Kyriachenko","year":"2019","unstructured":"Kyriachenko, Y., Falalyeyeva, T., Korotkyi, O. & Molochek, N. Kobyliak, N. Crosstalk between gut microbiota and antidiabetic drug action. World J. Diabetes. 10, 154\u2013168 (2019).","journal-title":"World J. Diabetes"},{"key":"7861_CR41","doi-asserted-by":"crossref","unstructured":"Montandon, S. A. & Jornayvaz, F. R. Effects of antidiabetic drugs on gut microbiota composition. Genes 8, (2017).","DOI":"10.3390\/genes8100250"},{"key":"7861_CR42","doi-asserted-by":"publisher","first-page":"e0132121","DOI":"10.1371\/journal.pone.0132121","volume":"10","author":"Y Ruan","year":"2015","unstructured":"Ruan, Y. et al. Effect of probiotics on glycemic control: A systematic review and meta-analysis of randomized, controlled trials. PLoS ONE. 10, e0132121 (2015).","journal-title":"PLoS ONE"},{"key":"7861_CR43","doi-asserted-by":"publisher","first-page":"803","DOI":"10.20452\/pamw.3156","volume":"125","author":"MA Kasi\u0144ska","year":"2015","unstructured":"Kasi\u0144ska, M. A. & Drzewoski, J. Effectiveness of probiotics in type 2 diabetes: A meta-analysis. Pol. Arch. Med. Wewn. 125, 803\u2013813 (2015).","journal-title":"Pol. Arch. Med. Wewn."},{"key":"7861_CR44","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1186\/s12967-023-04202-7","volume":"21","author":"C Hu","year":"2023","unstructured":"Hu, C. et al. Evaluating the distinct pleiotropic effects of omega-3 fatty acids on type 2 diabetes mellitus: a Mendelian randomization study. J. Translational Med. 21, 370 (2023).","journal-title":"J. Translational Med."},{"key":"7861_CR45","doi-asserted-by":"crossref","unstructured":"Lepretti, M., Martucciello, S., Aceves, M. A. B., Putti, R. & Lionetti, L. Omega-3 fatty acids and insulin resistance: focus on the regulation of mitochondria and endoplasmic reticulum stress. Nutrients 10, (2018).","DOI":"10.3390\/nu10030350"},{"key":"7861_CR46","first-page":"e4088","volume":"95","author":"C Li","year":"2016","unstructured":"Li, C. et al. Effect of probiotics on metabolic profiles in type 2 diabetes mellitus. Med. (United States). 95, e4088 (2016).","journal-title":"Med. (United States)"},{"key":"7861_CR47","doi-asserted-by":"crossref","unstructured":"Kobyliak, N. et al. Probiotic and omega-3 polyunsaturated fatty acids supplementation reduces insulin resistance, improves glycemia and obesity parameters in individuals with type 2 diabetes: A randomized controlled trial. Obesity Med. 19 (2020).","DOI":"10.1016\/j.obmed.2020.100248"},{"key":"7861_CR48","doi-asserted-by":"publisher","first-page":"108249","DOI":"10.1016\/j.jnutbio.2019.108249","volume":"74","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. Current level of fish and omega-3 fatty acid intakes and risk of type 2 diabetes in China. J. Nutr. Biochem. 74, 108249 (2019).","journal-title":"J. Nutr. Biochem."},{"key":"7861_CR49","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jnutbio.2018.09.004","volume":"62","author":"BF Bitner","year":"2018","unstructured":"Bitner, B. F. et al. Common gut microbial metabolites of dietary flavonoids exert potent protective activities in \u03b2-cells and skeletal muscle cells. J. Nutr. Biochem. 62, 95\u2013107 (2018).","journal-title":"J. Nutr. Biochem."},{"key":"7861_CR50","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11427-019-1647-6","volume":"64","author":"Q Li","year":"2021","unstructured":"Li, Q. et al. Hypoglycemic mechanism of polysaccharide from Cyclocarya paliurus leaves in type 2 diabetic rats by gut microbiota and host metabolism alteration. Sci. China Life Sci. 64, 117\u2013132 (2021).","journal-title":"Sci. China Life Sci."},{"key":"7861_CR51","doi-asserted-by":"publisher","first-page":"5898","DOI":"10.1039\/C9FO02761K","volume":"11","author":"G Wang","year":"2020","unstructured":"Wang, G. et al. Lactic acid bacteria reduce diabetes symptoms in mice by alleviating gut microbiota dysbiosis and inflammation in different manners. Food Funct. 11, 5898\u20135914 (2020).","journal-title":"Food Funct."},{"key":"7861_CR52","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.celrep.2017.01.062","volume":"18","author":"JH Kreznar","year":"2017","unstructured":"Kreznar, J. H. et al. Host genotype and gut Microbiome modulate insulin secretion and Diet-Induced metabolic phenotypes. Cell. Rep. 18, 1739\u20131750 (2017).","journal-title":"Cell. Rep."},{"key":"7861_CR53","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","volume":"165","author":"A Koh","year":"2016","unstructured":"Koh, A., De Vadder, F., Kovatcheva-Datchary, P. & B\u00e4ckhed, F. From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. Cell 165, 1332\u20131345 (2016).","journal-title":"Cell"},{"key":"7861_CR54","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1210\/me.2015-1007","volume":"29","author":"M Priyadarshini","year":"2015","unstructured":"Priyadarshini, M. et al. An acetate-specific GPCR, FFAR2, regulates insulin secretion. Mol. Endocrinol. 29, 1055\u20131066 (2015).","journal-title":"Mol. Endocrinol."},{"key":"7861_CR55","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/fsn3.2040","volume":"9","author":"S Tian","year":"2021","unstructured":"Tian, S., Li, X., Wang, Y. & Lu, Y. The protective effect of Sulforaphane on type II diabetes induced by high-fat diet and low-dosage streptozotocin. Food Sci. Nutr. 9, 747\u2013756 (2021).","journal-title":"Food Sci. Nutr."},{"key":"7861_CR56","doi-asserted-by":"publisher","unstructured":"Gonz\u00e1lez Hern\u00e1ndez, M. A., Canfora, E. E., Jocken, J. W. E. & Blaak, E. E. The Short-Chain fatty acid acetate in body weight control and insulin sensitivity. https:\/\/doi.org\/10.3390\/nu11081943 (2019).","DOI":"10.3390\/nu11081943"},{"key":"7861_CR57","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12866-021-02103-7","volume":"21","author":"J Chen","year":"2021","unstructured":"Chen, J. et al. Age-related changes of microbiota in midlife associated with reduced saccharolytic potential: an in vitro study. BMC Microbiol. 21, 47 (2021).","journal-title":"BMC Microbiol."},{"key":"7861_CR58","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1172\/JCI88877","volume":"127","author":"K Eguchi","year":"2017","unstructured":"Eguchi, K. & Nagai, R. Islet inflammation in type 2 diabetes and physiology. J. Clin. Invest. 127, 14\u201323 (2017).","journal-title":"J. Clin. Invest."},{"key":"7861_CR59","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41574-019-0286-3","volume":"16","author":"W Ying","year":"2020","unstructured":"Ying, W., Fu, W., Lee, Y. S. & Olefsky, J. M. The role of macrophages in obesity-associated islet inflammation and \u03b2-cell abnormalities. Nat. Reviews Endocrinol. 16, 81\u201390 (2020).","journal-title":"Nat. Reviews Endocrinol."},{"key":"7861_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22041509","volume":"22","author":"N Eguchi","year":"2021","unstructured":"Eguchi, N., Vaziri, N. D., Dafoe, D. C. & Ichii, H. The role of oxidative stress in pancreatic \u03b2 cell dysfunction in diabetes. Int. J. Mol. Sci. 22, 1\u201318 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"7861_CR61","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3389\/fcimb.2020.00188","volume":"10","author":"Z Hasain","year":"2020","unstructured":"Hasain, Z. et al. Gut microbiota and gestational diabetes mellitus: A review of Host-Gut microbiota interactions and their therapeutic potential. Front. Cell. Infect. Microbiol. 10, 188 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"7861_CR62","doi-asserted-by":"publisher","first-page":"101805","DOI":"10.1016\/j.molmet.2023.101805","volume":"77","author":"I Pavlo Petakh, Kamyshna","year":"2023","unstructured":"Pavlo Petakh, Kamyshna, I. & Kamyshnyi, A. Effects of Metformin on the gut microbiota: A systematic review. Mol. Metabolism. 77, 101805 (2023).","journal-title":"Mol. Metabolism"},{"key":"7861_CR63","doi-asserted-by":"crossref","unstructured":"Hsieh, P. S. et al. Multistrain probiotic supplement attenuates streptozotocin-induced type-2 diabetes by reducing inflammation and \u03b2-cell death in rats. PLoS ONE 16, (2021).","DOI":"10.1371\/journal.pone.0251646"},{"key":"7861_CR64","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1196\/annals.1293.017","volume":"1011","author":"Y Kajimoto","year":"2004","unstructured":"Kajimoto, Y. & Kaneto, H. Role of oxidative stress in pancreatic beta-cell dysfunction. Ann. N. Y. Acad. Sci. 1011, 168\u2013176 (2004).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"7861_CR65","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc19-S002","volume":"42","author":"2","year":"2019","unstructured":"2. Classification and diagnosis of diabetes: standards of medical care in diabetesd2019. Diabetes Care. 42, S13\u2013S28 (2019).","journal-title":"Diabetes Care"},{"key":"7861_CR66","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s13300-023-01474-6","volume":"14","author":"M Savytska","year":"2023","unstructured":"Savytska, M. et al. Probiotic for pancreatic \u03b2-Cell function in type 2 diabetes: A randomized, Double-Blinded, Placebo-Controlled clinical trial. Diabetes Therapy. 14, 1915\u20131931 (2023).","journal-title":"Diabetes Therapy"},{"key":"7861_CR67","doi-asserted-by":"publisher","first-page":"1276642","DOI":"10.3389\/fendo.2024.1276642","volume":"15","author":"M Savytska","year":"2024","unstructured":"Savytska, M. et al. Probiotic cosupplementation with absorbent smectite for pancreatic beta-cell function in type 2 diabetes: a secondary-data analysis of a randomized double-blind controlled trials. Front. Endocrinol. 15, 1276642 (2024).","journal-title":"Front. Endocrinol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07861-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07861-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07861-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T14:20:17Z","timestamp":1759242017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07861-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7861"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-07861-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"25 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33870"}}